Logo-ijbsm
Submitted: 07 Aug 2021
Revision: 22 Aug 2021
Accepted: 13 Nov 2021
ePublished: 30 Dec 2021
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Int J Basic Sci Med. 2021;6: 152-156.
doi: 10.34172/ijbsm.2021.27
  Abstract View: 101
  PDF Download: 80

Original Article

The Assessment of Complement Proteins in Patients With Severe COVID-19

Ali Ghazavi 1, 2 ORCID logo, Ghasem Mosayebi 1, 2, Nafiesh Keshavarzian 1, Somayeh Rabiemajd 3, Ali Ganji 1*

1 Molecular and Medicine Research Center, Department of Microbiology and Immunology, School of Medicine, Arak University of Medical Sciences, Arak, Iran
2 Traditional and Complementary Medicine Research Center (TCMRC), Department of Microbiology and Immunology, School of Medicine, Arak University of Medical Sciences, Arak, Iran
3 Department of Microbiology and Immunology, School of Medicine, Arak University of Medical Sciences, Arak, Iran
*Corresponding Author: *Correspondence to Ali Ganji, Molecular and Medicine Research Center, Department of Microbiology and Immunology, School of Medicine, Arak University of Medical Sciences, Arak, Iran Tel:+98 86 34173502. Fax:+98 86 34173526. E-mail: , Email: a.ganji@arakmu.ac.ir

Abstract

Introduction: The complement system, consisting of more than 20 soluble proteins, has a crucial role in innate immunity and inflammation and eliminates pathogens and viral infections. Therefore, we investigated the titers of C3, C4, and total IgG in the sera of non-severe and severe coronavirus disease 2019 (COVID-19) patients.

Methods: For this purpose, peripheral blood samples were collected from 30 non-severe and 30 severe COVID-19 patients and 30 healthy individuals with similar age and sex as the control group. The serum levels of total IgG, C3, and C4 were analyzed. Also, white blood cells, platelets (PLTs), and lymphocytes were counted by an auto-analyzer.

Results: White blood cell count showed no difference between COVID-19 patients and the control group. The results showed a significant decrease in lymphocyte and PLT counts in COVID-19 patients compared to the control. Complement proteins, including C3 and C4, were increased in non-severe COVID-19 patients (C3; P=0.017 and C4; P=0.012) compared to other groups. Total IgG showed a notable decrease in severe COVID-19 patients.

Conclusion: The decrease in C3 and C4 complement factors in severe COVID-19 patients may be due to further consumption secondary to the formation of immune complexes. By clarifying the role of complement proteins of C3 and C4 in different stages of the disease, our results can be helpful in designing therapeutic and diagnostic measures for the disease.

Keywords: COVID-19, Complement, C3, C4, IgG, Inflammation

Please cite this article as follows: Ghazavi A, Mosayebi G, Keshavarzian N, Rabiemajd S, Ganji A. The assessment of complement proteins in patients with severe covid-19. Int J Basic Sci Med. 2021;6(4):152- 156. doi:10.34172/ ijbms.2021.27.
First Name
 
Last Name
 
Email Address
 
Comments
 
Security code


Abstract View: 102

Your browser does not support the canvas element.


PDF Download: 80

Your browser does not support the canvas element.